New R&D hub aims for digitally-integrated manufacturing processes

A new Australian Research Council (ARC) Hub to help forge an internationally competitive Australian biopharmaceutical sector using digitisation and artificial intelligence (AI) in pharmaceutical manufacturing has been launched at the University of Melbourne. ARC Acting CEO Dr Richard Johnson inaugrated the ARC Digital Bioprocess Development Hub – a five-year, $18 million research programme, which has…

Best of the week — the five most popular stories among @AuManufacturing’s readers

What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Hydrogen energy company Endua raises $11.8 million Green energy company Endua announced that it has raised $7.5 million in pre-series private funding, with new investors including Queensland Investment Corporation (QIC), Melt Ventures and 77 Partners. The company…

CSL’s biggest manufacturing investment reaches milestone

Vaccine company CSL Seqirus has announced the ‘topping out’ of the construction of its biggest investment project, its new state-of-the-art manufacturing facility in Melbourne (pictured). The facility will use innovative technology to produce seasonal and pandemic cell-based influenza vaccines, CSL Seqirus’ vaccine adjuvant technology (MF59), the world’s only approved human vaccine for Q fever and…